Skip Navigation



NDT Advance Access published online on August 25, 2006

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl469
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/12/3428    most recent
gfl469v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Navarro, J. F.
Right arrow Articles by García, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navarro, J. F.
Right arrow Articles by García, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received May 22, 2006
Accepted July 11, 2006


Original Article

Urinary tumour necrosis factor-{alpha} excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients

Juan F. Navarro 1 *, Carmen Mora 2, Mercedes Muros 3, and Javier García 4

1 Nephrology Service, University Hospital, Santa Cruz de Tenerife, Spain; Research Unit, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain; Centre for Biological Research, Spanish National Research Council, Madrid, Spain
2 Research Unit, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain; Centre for Biological Research, Spanish National Research Council, Madrid, Spain
3 Research Unit, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain; Centre for Biological Research, Spanish National Research Council, Madrid, Spain; Clinical Biochemistry Service, Universitary Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
4 Nephrology Service, University Hospital, Santa Cruz de Tenerife, Spain

* To whom correspondence should be addressed.
Juan F. Navarro, E-mail: jnavgon{at}gobiernodecanarias.org



  Abstract

Background. Inflammation is a potential factor in the development and progression of diabetic nephropathy. The aim of this study was to analyse the relationship between the pro-inflammatory cytokine tumour necrosis factor-{alpha} (TNF{alpha}) and clinical markers of glomerular and tubulointerstitial damage [urinary albumin excretion (UAE) and urinary N-acetyl-{beta}-glucosaminidase (UNAG), respectively] in a large group of type 2 diabetic patients.

Methods. A total of 160 diabetic patients and 32 healthy controls were included in the study. High-sensitive C-reactive protein (hs-CRP) as well as serum and urinary levels of TNF{alpha} were measured. UAE and UNAG were determined by 24-h urine collection.

Results. Serum hs-CRP and TNF{alpha} were significantly higher in diabetic than in control subjects, as well as UAE and UNAG. Diabetic patients had increased urinary TNF{alpha} compared to non-diabetics [14.5 (2-29) vs 4 (0.8-12), P < 0.001]. Serum hs-CRP and TNF{alpha} in diabetics with increased UAE were elevated compared to diabetics having normoalbuminuria. Urinary TNF{alpha} was also higher in diabetic subjects with micro- or macroalbuminuria than in patients with normal UAE [10.5 (4-20) and 18 (9-29) vs 7 (2-18) pg/mg, P < 0.0001, respectively]. Multiple regression analysis showed that urinary TNF{alpha} (P < 0.0001), hs-CRP (P < 0.0001), serum TNF{alpha} (P < 0.01) and HbA1c (P < 0.05) were independent of and significantly associated with UAE, whereas duration of diabetes (P < 0.001), urinary TNF{alpha} (P < 0.01), HbA1c (P = 0.01), hs-CRP (P < 0.05) and serum creatinine (P < 0.05) were associated with UNAG.

Conclusions. In patients with type 2 diabetes, urinary TNF{alpha} excretion is elevated and correlates with severity of renal disease in terms of both glomerular and tubulointerstitial damage, suggesting a significant role for TNF{alpha} in the pathogenesis and progression of renal injury in diabetes mellitus.

Keywords: albuminuria; cytokines; diabetes mellitus; diabetic nephropathy; tumour necrosis factor-{alpha}.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
P. P. Wolkow, M. A. Niewczas, B. Perkins, L. H. Ficociello, B. Lipinski, J. H. Warram, and A. S. Krolewski
Association of Urinary Inflammatory Markers and Renal Decline in Microalbuminuric Type 1 Diabetics
J. Am. Soc. Nephrol., April 1, 2008; 19(4): 789 - 797.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. F. Navarro, C. Mora, M. Gomez, M. Muros, C. Lopez-Aguilar, and J. Garcia
Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-{alpha} and interleukin-6 in type 2 diabetic patients
Nephrol. Dial. Transplant., March 1, 2008; 23(3): 919 - 926.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. F. Navarro-Gonzalez and C. Mora-Fernandez
The Role of Inflammatory Cytokines in Diabetic Nephropathy
J. Am. Soc. Nephrol., March 1, 2008; 19(3): 433 - 442.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.